{
    "Title": "2,4-Diaminopyrimidines as Potent Inhibitors of Trypanosoma brucei and Identification of Molecular Targets by a Chemical Proteomics Approach",
    "URL": "https://doi.org/10.1371/journal.pntd.0000956",
    "Published": "February 8, 2011",
    "Subject_Areas": [
        "Trypanosoma brucei gambiense",
        "African trypanosomiasis",
        "Parasitic diseases",
        "Trypanosoma",
        "Protozoans",
        "Leishmania",
        "Mouse models",
        "Parasitic protozoans"
    ],
    "Authors": {
        "Luke Mercer": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ],
        "Tana Bowling": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ],
        "Joe Perales": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ],
        "Jennifer Freeman": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ],
        "Tien Nguyen": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ],
        "Cyrus Bacchi": [
            "Haskins Laboratories, Pace University, New York, New York, United States of America"
        ],
        "Nigel Yarlett": [
            "Haskins Laboratories, Pace University, New York, New York, United States of America"
        ],
        "Robert Don": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Robert Jacobs": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ],
        "Bakela Nare": [
            "SCYNEXIS Inc., Research Triangle Park, North Carolina, United States of America"
        ]
    }
}